logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • Cookie opt-out
  • Cookie opt-out
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Samples
    2. /
    3. Leqvio
    Cardiovascular

    Leqvio Samples

    inclisiran

    Manufacturer
    Novartis
    Indication
    siRNA for LDL-C reduction in ASCVD or HeFH
    Sample Info: Twice-yearly dosing after initial doses.

    How It Works

    1
    Enter your NPI number and email address
    2
    We check your eligibility with Novartis
    3
    Order samples instantly or request access
    Free for healthcare providers
    350K+ providers use PrescriberPoint

    Leqvio Sample FAQs

    Are Leqvio samples available for healthcare providers?

    Leqvio samples may be available through Novartis's patient access programs. Check your eligibility on PrescriberPoint by entering your NPI number to see current availability.

    How do I get free Leqvio samples?

    To request free Leqvio (inclisiran) samples, enter your NPI number on PrescriberPoint. We'll instantly verify your eligibility with Novartis and show you how to order samples. The process takes less than a minute and is completely free for licensed prescribers.

    Who is eligible for Leqvio drug samples?

    Licensed healthcare providers including physicians (MDs, DOs), nurse practitioners, and physician assistants with valid NPI numbers may be eligible for Leqvio samples. Eligibility is determined by Novartis based on your prescribing credentials and state licensing. PrescriberPoint checks your eligibility instantly.

    How long does it take to receive Leqvio samples?

    Delivery times for Leqvio samples from Novartis typically range from 2-4 weeks after your request is approved. Some manufacturers offer expedited shipping. You'll receive confirmation once your samples are processed.

    More from Novartis

    View all
    Entresto
    sacubitril/valsartan
    Cardiovascular
    Cosentyx
    secukinumab
    Immunology
    Aimovig
    erenumab-aooe
    Neurology
    Kesimpta
    ofatumumab
    Neurology
    Kisqali
    ribociclib
    Oncology

    More Cardiovascular Samples

    View all
    Eliquis
    apixaban
    Pfizer
    Xarelto
    rivaroxaban
    Janssen (J&J)
    Repatha
    evolocumab
    Amgen
    Brilinta
    ticagrelor
    AstraZeneca
    Pradaxa
    dabigatran etexilate
    Boehringer Ingelheim

    Popular Samples

    Browse all
    Ozempic
    semaglutide injection
    Novo Nordisk
    Diabetes
    Keytruda
    pembrolizumab
    Merck
    Oncology
    Dupixent
    dupilumab
    Sanofi
    Immunology
    Eylea
    aflibercept
    Regeneron
    Ophthalmology
    105+
    Products Available
    50+
    Manufacturers
    20+
    Therapeutic Areas